Doctor profile · Federal record
Dr. David Porter, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Philadelphia, PA
- NPI 1780627075
- Accepts Medicare
- MIPS 85.5 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3400 Spruce St, 15 Penn Tower
Philadelphia, PA 19104
(215) 662-3914
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- March 23, 2011
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Pennsylvania #MD057776L
- Medicaid
- PA #001559986000
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1780627075. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
204
Distinct HCPCS
2
Medicare allowed
$23,611
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 142 | 85 | $101 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 62 | 31 | $149 |
In context: peer comparison
Among 59 peers in this city , average services per provider: 829. This provider delivers 0.2× the peer median.Open Payments
Industry payments received
All-time total
$5,485
Transactions
14
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $2,160.26 | |
| Novartis Pharma AG | 2 | $2,010.98 | |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $413.33 | |
| Cardinal Health 110 LLC | 1 | $387.50 | |
| Novartis Pharmaceuticals Corporation | 4 | $313.86 | |
| Genmab U.S., Inc. | 1 | $81.59 | |
| McKesson Sourcing Services, Inc. | 2 | $62.67 | |
| National Marrow Donor Program | 1 | $55.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
291
Patients
0
Total drug cost
$3,075,281
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Imbruvica (Ibrutinib) | Brand | 77 | 0 | $1,254,257 |
| Calquence (Acalabrutinib Maleate) | Brand | 35 | 0 | $516,761 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 28 | 0 | $2,970 |
| Acyclovir | Generic | 20 | 0 | $276 |
| Sprycel (Dasatinib) | Brand | 18 | 0 | $177,443 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 14 | 0 | $363,085 |
| Rezurock (Belumosudil Mesylate) | Brand | 14 | 0 | $228,568 |
| Ursodiol | Generic | 14 | 0 | $539 |
| Prednisone | Generic | 13 | 0 | $88 |
| Cresemba (Isavuconazonium Sulfate) | Brand | 12 | 0 | $73,443 |
Frequently asked questions
What is Dr. David Porter's medical specialty?
Dr. David Porter practices Hematology & Oncology Physician in Philadelphia, PA.
Where does Dr. David Porter practice?
Dr. David Porter practices at 3400 Spruce St, Philadelphia, PA 19104. Office phone: 2156623914.
What is Dr. David Porter's NPI?
Dr. David Porter's National Provider Identifier (NPI) is 1780627075, issued by NPPES.
Does Dr. David Porter accept Medicare assignment?
Yes. Dr. David Porter accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Porter commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.